Skip to content
Screener

OSI Systems OSIS Healthcare Division — Research And Development Expense

Other segment segments

Security Division
$13.55M+4.2%
Optoelectronics And Manufacturing Division
$1.28M+0.9%

Similar metrics at other companies

RFL
RFLHealthcare One — Research And Development Expense
$4.85M+61.6%
CareCloud, Inc. logo
CCLDHealthcare IT — Research And Development Expense
$2.19M+115%
Church & Dwight logo
CHDSpecialty Products Division — Research And Development Expense
$800K+33.3%
Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%

Other financials

Income statement

See full
Revenue$453.2M+2.0%
Gross profit$150.3M0.0%
Operating income$53.2M-5.3%
Net income$40.2M-2.2%
EPS (diluted)$2.33-2.9%

Balance sheet

See full
Cash & equivalents$345.2M+260%
Total debt$1.0B+107%
Total equity$894.3M+1.7%
Total assets$2.6B+22.8%

Cash flow

See full
Operating cash flow$14.5M-82.3%
CapEx$7.6M+67.3%
Free cash flow$6.9M-91.1%

Valuation

See full
Market cap$3.91B+5.3%
Enterprise value$4.61B+12.1%
P/E25.7×+0.9×
P/S2.2×0.0×

Profitability

See full
Gross margin32.8%-1.1pp
Operating margin12.1%-0.2pp
Net margin8.4%0.0pp
FCF margin4%+1.5pp

Returns & leverage

See full
Return on equity17.2%+0.4pp
Debt / equity1.2×+0.6×
Current ratio3.2×+1.1×

Where this comes from

Reported directly by OSI Systems in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: OSI Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 5:24 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-055014
Line itemSecurity / DivisionOptoelectronics / and / Manufacturing / DivisionHealthcare / DivisionCorporate/ / EliminationsConsolidated
Total revenues319,263110,99840,701(17,716)453,246
Cost of goods sold213,14187,21920,167(17,605)302,922
Selling, general and administrative expenses37,1727,88415,63710,79471,487
Research and development expenses13,5461,2824,62719,455
Segment income (loss) from operations55,40414,613270(10,905)59,382
Impairment, restructuring and other charges1,4332,6362,0996,168
Income (loss) from operations$53,971$14,613$(2,366)$(13,004)$53,214
Capital expenditures$5,681$834$690$354$7,559

Item 1. Financial Statements (Unaudited)

FAQ

What is OSI Systems's healthcare division — research and development expense?
OSI Systems (OSIS) reported healthcare division — research and development expense of $4.63M in Q1 2026.
How has OSI Systems's healthcare division — research and development expense changed year-over-year?
OSI Systems's healthcare division — research and development expense increased by 7.7% year-over-year, from $4.3M to $4.63M.
What is the long-term trend for OSI Systems's healthcare division — research and development expense?
Over 2 years (2023 to 2025), OSI Systems's healthcare division — research and development expense has grown at a 2.1% compound annual growth rate (CAGR), from $16.56M to $17.25M.
What does healthcare division — research and development expense mean?
Captures the investment in developing new healthcare technologies, products, and clinical solutions. This metric is a critical indicator of the segment's commitment to innovation and its long-term strategy for maintaining a competitive advantage in the medical device market.

Ask your AI about OSI Systems's healthcare division — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude